Aurobindo Pharma Ltd. has received 54th approval of the U.S. Food and Drug Administration(USFDA) to manufacture and market Famotidine tablet that is used for the short-term treatment of gastroesophageal reflux disease and active duodenal ulcer.
- The approved abbreviated new drug application (ANDA) is bio and therapeutically equivalent to the reference listed drug product Pepcid tablets of Valeant Pharmaceuticals International Inc., the Hyderabad firm.
- With this, Aurobindo has a total of 226 ANDA approvals.
No comments:
Post a Comment